Article Impact Level: HIGH Data Quality: STRONG Summary of Circulation. https://dx.doi.org/10.1161/circulationaha.125.078336 Dr. Victoria R. Palzkill et al.
Points
- Researchers evaluated muscle samples from patients with peripheral artery disease and discovered that fat accumulation within the muscle tissue acts as a direct instigator of limb weakness and dysfunction.
- The study found that genes responsible for creating fat cells are significantly more active in patients with advanced arterial narrowing than in healthy individuals which leads to skeletal muscle marbling.
- Experimental data from animal models demonstrated that high levels of intramuscular fat caused persistent muscle weakness even after the researchers successfully restored normal blood flow to the affected limbs.
- By altering the specific proteins that regulate fat production investigators were able to improve muscle strength without changing the circulatory volume which identifies a new potential target for medical therapy.
- These findings suggest that preventing muscle from turning into fat is just as important as reopening blocked arteries for improving the long term quality of life for heart patients.
Summary
This research evaluated the pathological role of intramuscular adipose tissue (IMAT) in patients with peripheral artery disease (PAD) and chronic limb-threatening ischemia (CLTI). While standard clinical interventions focus primarily on the restoration of macrovascular blood flow, over 200 million people worldwide remain at risk for persistent muscle weakness and limb loss. Investigators analyzed calf muscle biopsies to determine if the accumulation of fat within skeletal muscle acts as an independent instigator of limb dysfunction rather than a passive byproduct of ischemia.
The analysis revealed that increased IMAT levels directly correlate with impaired muscle performance, even in subjects with normalized perfusion. Transcriptomic profiling of muscle samples from CLTI patients showed significantly higher activity in genes responsible for adipogenesis compared to healthy controls. In murine models, the presence of extensive IMAT resulted in profound muscular weakness despite the successful restoration of blood flow. However, by pharmacologically or genetically modulating the proteins regulating fat production, researchers achieved significant improvements in contractile force without requiring changes in arterial diameter or circulatory volume.
These findings suggest that the pathobiology of advanced PAD involves a fundamental shift in muscle composition that standard revascularization fails to address. The study highlights IMAT as a distinct therapeutic target, challenging the conventional view that limb-threatening ischemia is exclusively a vascular problem. Preventing the conversion of skeletal muscle into adipose tissue may provide a necessary adjunct to surgical intervention for improving walking performance and quality of life. Future clinical strategies should prioritize the development of myocellular-targeted therapies to mitigate the fibro-fatty degeneration that drives long-term disability in the PAD population.
Link to the article: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.125.078336
References
Victoria R. Palzkill et al, Intramuscular Adipose Tissue Accumulation is a Key Determinant of Limb Function in Peripheral Artery Disease, Circulation (2026). https://dx.doi.org/10.1161/circulationaha.125.078336
